You are here: Industry Insights > Merck

News List

IO Biotech, Merck to Evaluate KEYTRUDA Combo in NSCLC contractpharma
March 13, 2018
IO Biotechhas entered into a collaborative agreement with Merck focused on the clinical evaluation of IO102 with KEYTRUDA (pembrolizumab) in non-small cell lung cancer (NSCLC).
Immutep Strikes Deal with Merck to Pair Product With Keytruda in Phase II Trial biospace
March 13, 2018
Australian Immutep Ltd. announced that it will use Merck’s heavy PD-1 inhibitor Keytruda to pair its primary immunotherapy product with three solid tumor types in a single trial.
Merck shows canny cancer strategy in $5.76bn Eisai milestones deal pharmaphorum
March 12, 2018
Merck & Co and Eisai have reached a deal to co-develop and jointly market Keytruda and Lenvima in a deal that could generate $5.76 billion for the Japanese pharma company
Merck and Eisai Ink $5.76B Cancer Deal biospace
March 09, 2018
Merck & Company and Tokyo-based Eisai Inc. have signed a strategic collaboration deal to develop and commercialize Lenvima (lenvatinib mesylate) with Merck’s anti-PD-1 drug Keytruda (pembrolizumab).
Merck KGaA, Darmstadt, Germany, Announces Positive Phase IIB Results for Evobrutinib in Relapsing Mu biospace
March 08, 2018
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced positive results from its Phase IIb study of evobrutinib in relapsing multiple sclerosis (MS)
Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel worldpharmanews
March 01, 2018
Merck announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel.
Merck invests additional €40 M to enhance services in Asia biospectrumasia
February 26, 2018
Merck is investing in a robust manufacturing and distribution platform in Asia to support the growing demand for biopharmaceutical research.
Gardasil's growth led Merck's vaccine sales of $6.5B in 2017 as Zostavax struggles fiercepharma
February 07, 2018
Merck's vaccine business kept churning in 2017, generating sales of $6.5 billion and growing by 4.8% over the prior year.
Merck celebrates its 350th anniversary worldpharmanews
February 06, 2018
Merck, a leading science and technology company, will celebrate its 350th anniversary this year with customers, partners and employees under the motto "Past.
Merck expects a flat tax rate in 2018 as peers see benefit from reform fiercepharma
February 05, 2018
Merck executives praised the U.S. government for tax reform on Friday, but the drugmaker is projecting a flat tax rate this year as many of its peers expect a benefit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page